Literature DB >> 12590906

Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings.

D Holmgren1, H Wåhlander, B O Eriksson, A Oldfors, E Holme, M Tulinius.   

Abstract

AIMS: To determine the frequency of cardiomyopathy in children with mitochondrial disease and describe their clinical course, prognosis and cardiological manifestations. METHODS AND
RESULTS: Of 301 children with CNS and neuromuscular disease referred to our institution in 1984 to 1999, 101 had mitochondrial disease. Seventeen patients had cardiomyopathy, diagnosed by echo-Doppler investigations, all of the hypertrophic, non-obstructive type. The onset of symptomatic mitochondrial disease ranged from birth to 10 years of age. Eight children had cytochrome-c oxidase deficiency, while the remaining nine had various defects. Cardiomyopathy was diagnosed from birth to 27 years. Left ventricular posterior wall and septal thickness were both increased: z-scores +4.6+/-2.6 and +4.3+/-1.6 (mean+/-SD), respectively. The left ventricular diastolic diameter z-score, +1.3+/-3.4, and fractional shortening, 24+/-13%, displayed marked variations. Nine patients developed heart failure. Eleven patients with cardiomyopathy died, including all eight with cytochrome-c oxidase deficiency, and one patient underwent a heart transplantation. Mortality in children with mitochondrial disease was higher in those with cardiomyopathy (71%) than those without (26%) (P<0.001).
CONCLUSIONS: In children with mitochondrial disease, cardiomyopathy was common (17%) and was associated with increased mortality. The prognosis for children with cytochrome-c oxidase deficiency and cardiomyopathy appeared to be particularly unfavorable.

Entities:  

Mesh:

Year:  2003        PMID: 12590906     DOI: 10.1016/s0195-668x(02)00387-1

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  60 in total

1.  Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Matthias Ponfick; Sabine Rösch; Alfred Lindner; Albert C Ludolph; Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2011-12-06       Impact factor: 5.460

Review 2.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 3.  Mitochondrial dynamic changes in health and genetic diseases.

Authors:  Le Chen; Allison J Winger; Anne A Knowlton
Journal:  Mol Biol Rep       Date:  2014-11       Impact factor: 2.316

Review 4.  Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease.

Authors:  Farzaneh G Tahrir; Dianne Langford; Shohreh Amini; Taha Mohseni Ahooyi; Kamel Khalili
Journal:  J Cell Physiol       Date:  2018-11-11       Impact factor: 6.384

5.  Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy.

Authors:  Josef Finsterer; Finsterer Josef; Claudia Stöllberger; Stöllberger Claudia; Ellen Gelpi; Gelpi Ellen
Journal:  Int J Cardiovasc Imaging       Date:  2006-02-25       Impact factor: 2.357

Review 6.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

Review 7.  Genetics and metabolic cardiomyopathies.

Authors:  E C Wicks; P M Elliott
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

8.  Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?

Authors:  P Freisinger; R Horvath; C Macmillan; J Peters; M Jaksch
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Electrocardiography as an early cardiac screening test in children with mitochondrial disease.

Authors:  Ran Baik; Jung Hyun Chae; Young Mock Lee; Hoon Chul Kang; Joon Soo Lee; Heung Dong Kim
Journal:  Korean J Pediatr       Date:  2010-05-31

10.  Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene.

Authors:  Johan L K Van Hove; Cynthia Freehauf; Shelley Miyamoto; Georgirene D Vladutiu; Jacklyn Pancrudo; Eduardo Bonilla; Mark A Lovell; Gary W Mierau; Janet A Thomas; Sara Shanske
Journal:  Eur J Pediatr       Date:  2007-09-22       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.